Evelin Melekh

Evelin Melekh

Auto-generated profile, based on publicly available information

Evelin Melekh

Brock University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2023 in EMBO Molecular Medicine
Verified
Journal Article
Open access
Pazhanichamy KalailingamPazhanichamy Kalailingam
Pazhanichamy Kalailingam
KMKhalilatul‐Hanisah Mohd‐Kahliab
Khalilatul‐Hanisah Mohd‐Kahliab
SNSoFong Cam Ngan
SoFong Cam Ngan
RIRanjith Iyappan
Ranjith Iyappan
EMEvelin Melekh
Evelin Melekh
SSSiu Kwan Sze
Siu Kwan Sze
Aging results from the accumulation of molecular damage that impairs normal biochemical processes. We previously reported that age‐linked damage to amino acid sequence NGR (Asn‐Gly‐Arg) results in “gain‐of‐function” conformational switching to isoDGR (isoAsp‐Gly‐Arg). This integrin‐binding motif activates leukocytes and promotes chronic inflammation, which are characteristic features of age‐linked cardiovascular disorders. We now report that anti‐isoDGR immunotherapy mitigates lifespan reduction of Pcmt1 −/− mouse. We observed extensive accumulation of isoDGR and inflammatory cytokine expression in multiple tissues from Pcmt1 −/− and naturally aged WT animals, which could also be induced via injection of isoDGR‐modified plasma proteins or synthetic peptides into young WT animals. However, weekly injection of anti‐isoDGR mAb (1 mg/kg) was sufficient to significantly reduce isoDGR‐protein levels in body tissues, decreased pro‐inflammatory cytokine concentrations in blood plasma, improved cognition/coordination metrics, and extended the average lifespan of Pcmt1 −/− mice. Mechanistically, isoDGR‐mAb mediated immune clearance of damaged isoDGR‐proteins via antibody‐dependent cellular phagocytosis (ADCP). These results indicate that immunotherapy targeting age‐linked protein damage may represent an effective intervention strategy in a range of human degenerative disorders.

28 November 2024 in Healthy Populations Journal
Verified
Journal Article
Open access
PDF file
ASAlison Smoke
Alison Smoke
SWStephanie Wadge
Stephanie Wadge
ABAllayna Barrett
Allayna Barrett
SNSophia Nikitin
Sophia Nikitin
EMEvelin Melekh
Evelin Melekh
CMCaitlin Muhl
Caitlin Muhl
Introduction: As the social prescribing movement grows in Canada, there is a need to understand whether students (a) are aware of this concept and (b) think it is important. Objectives: The aim of this study was to examine student perceptions and awareness of social prescribing in a Canadian university. Methods: This study was conducted at Brock University. Data collection took place between March and June of 2023. Eligibility criteria included (a) being a student at Brock University and (b) being able to read and write English. Participants completed an online survey. Quantitative data analysis consisted of basic mathematical computations. Qualitative data analysis consisted of qualitative content analysis. Results: Most participants (138/183, 75.4%) had never heard about social prescribing before. Once they were told what social prescribing is, the vast majority of participants thought that it seemed like a useful way to support health and well-being (121/126, 96.0%), felt that offering it on campus would be beneficial (129/130, 99.2%), believed that it is relevant to future health care professionals (121/128, 94.5%), thought that it should be part of the curriculum for health sciences programs (118/128, 92.2%), and expressed that they would be willing to follow their physician’s advice if they were to suggest social prescribing at an appointment (119/126, 94.4%). Conclusion/Discussion: Given the lack of awareness about social prescribing and the positive perceptions about this concept among the student body, Canadian post-secondary institutions are encouraged to (a) integrate this concept into the curriculum for health sciences programs and (b) offer social prescribing on campus.

28 August 2026 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
EMEvelin Melekh
Evelin Melekh
ECEmma L. Cook
Emma L. Cook
JSJulia G. Stante
Julia G. Stante
AMAmélie A. T. Marais
Amélie A. T. Marais
AMAhmad Mohammad
Ahmad Mohammad
RMRebecca MacPherson
Rebecca MacPherson
A major barrier in AD research is the lack of animals that recapitulate sporadic AD, which accounts for most human cases. Recently, a novel mouse model (hAβ‐KI) was developed by introducing a three‐point mutation that humanizes the beta‐amyloid peptide. These mice exhibit age‐dependent cognitive decline and beta‐amyloid accumulation. However, limited research has been conducted related to AD risk factors and sex‐specific responses in this model. Male and female control and hAß‐KI mice were assessed at ages 4, 8, 10, 12 and 15 months. Body composition (bone mineral density, lean and fat mass) and metabolic function (respiratory exchange rate, energy expenditure, and activity levels) were evaluated, in addition to insulin tolerance testing (ITT). An open field test (OFT) was performed to evaluate anxiety‐like behaviors, and novel object location (NOLT) and recognition tests (NORT) were conducted to measure cognitive impairment at endpoint. With aging, the male hAß‐KI mice exhibited increased body and fat mass %, decreased lean mass %, decreased activity, and impaired glucose handling prior to confirmed cognitive impairment by NORT and NOLT. In contrast, the female hAß‐KI did not display similar differences compared to controls. These findings support the utility of this model as a valuable tool for investigating systemic risk factors related to sporadic AD, and the absence of similar differences in the females highlights the importance of considering sex as a variable in AD pathology.

18 June 2025 in The Journal of Physiology
Verified
Journal Article
Closed access
EMEvelin Melekh
Evelin Melekh
MKMadeleine King
Madeleine King
JSJulia G. Stante
Julia G. Stante
ECEmma L. Cook
Emma L. Cook
GSGrace Sargeant
Grace Sargeant
SBSarah Bellaflor
Sarah Bellaflor

1 September 2026 in Journal of Neurophysiology
Verified
Journal Article
Open access
MMMadeleine Gene Maheu
Madeleine Gene Maheu
JMJulia Mazur
Julia Mazur
EMEvelin Melekh
Evelin Melekh
MKMadeleine King
Madeleine King
GAGurprince Attlas
Gurprince Attlas
Paula Duarte GutermanPaula Duarte Guterman
Paula Duarte Guterman
Our work highlights the contrast between anxiogenic and anxiolytic effects of acute vs. chronic exercise, respectively, in healthy mice. Acute and chronic exercise differentially affected circulating and brain cytokines, providing insight into physiological adaptations to exercise. Both sexes demonstrated similar cytokine responses to exercise. These similarities are novel with respect to exercise research and noteworthy given sex differences in anxiety with respect to acute exercise.